Elutia Inc Revenue per Employee (ELUT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Elutia Inc   (NASDAQ: ELUT)
 

Elutia Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Elutia Inc 's Revenue per employee fell on a trailing twelve month basis to $ 370,654, but the productivity of Elutia Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 170 other companies have achieved higher revenue per employee. While Elutia Inc 's total ranking has deteriorated compared to the previous quarter from 1377 to 1531. Elutia Inc has 26 employees.


What is Sales per Employee Ratio?







ELUT Revenue per Employee (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Revenue Change -60.15 % -59.94 % -48.65 % -48.28 % -50.3 %
Sales per Employee (TTM) $ 370,654 436,654 576,308 678,423 795,846
ELUT's Total Ranking # 1531 # 1377 # 1224 # 0 #
Seq. Revenue Change -53.15 % -13.38 % -14.34 % 14.65 % -52.91 %


Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 24
Healthcare Sector # 171
Overall Market # 1531

Revenue per Employee Statistics
High Average Low
$ 1,951,615 $ 1,190,028 $ 379,269
(Mar 31 2023)   (Jun 30 2026)



Financial Statements
Elutia Inc 's Revenue MRQ $ 1 Millions Visit ELUT's Income Statement
Elutia Inc 's Revenues TTM $ 10 Millions Visit ELUT's aggregate revenue growth
What are ELUT's Sales? Visit ELUT's Sales by Segment




Other Ratios
Elutia Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ELUT's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ELUT's Competitors
Revenue per Employee for ELUT's Suppliers
Revenue per Employee for ELUT's Customers

You may also want to know
ELUT's Sales Growth Rates ELUT's Pe Price to earnings ratio ELUT's Receivables Turnover Ratio ELUT's Stock Quote
ELUT's Net Income Growth Rates ELUT's Ps Price to Sales ratio ELUT's Sales per Employee ELUT's Asset Turnover Ratio
ELUT's Net Margin ELUT's Pb Price to Book ratio ELUT's Financial Strength Ratios ELUT's Dividend Payout Ratio
Date modified: 2026-11-11T13:41:29+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Koru Medical Systems Inc   633,862.01 $ 46.272  Million 73 
Organon and Co   611,100.00 $ 6,111.000  Million 10,000 
Bioventus Inc   609,707.29 $ 585.319  Million 960 
Si bone inc   590,928.19 $ 222.189  Million 376 
Coya Therapeutics Inc   586,128.13 $ 4.689  Million 8 
Butterfly Network Inc   562,340.91 $ 123.715  Million 220 
Carlsmed Inc   559,716.54 $ 71.084  Million 127 
Beone Medicines Ltd   550,523.25 $ 6,606.279  Million 12,000 
Novavax inc   549,598.13 $ 411.649  Million 749 
Henry Schein Inc   549,360.00 $ 13,734.000  Million 25,000 
Bausch Health Companies Inc   547,438.42 $ 11,113.000  Million 20,300 
Iradimed Corporation  538,192.16 $ 89.340  Million 166 
Glaukos Corp  528,660.88 $ 578.355  Million 1,094 
Alpha Pro Tech Ltd   527,967.48 $ 64.940  Million 123 
Orthofix Medical Inc   520,674.77 $ 835.683  Million 1,605 
Angiodynamics Inc   512,316.46 $ 323.784  Million 632 
Resmed Inc   505,115.57 $ 5,743.164  Million 11,370 
Cardiff Lexington Corporation  503,682.17 $ 9.066  Million 18 
Avantor Inc   491,525.93 $ 6,635.600  Million 13,500 
Gossamer Bio Inc   484,092.59 $ 78.423  Million 162 
Lexicon Pharmaceuticals Inc   475,765.43 $ 38.537  Million 81 
Stryker Corp  469,642.86 $ 26,300.000  Million 56,000 
Monte Rosa Therapeutics Inc   468,833.33 $ 70.325  Million 150 
Trisalus Life Sciences Inc   464,676.47 $ 47.397  Million 102 
Dexcom Inc   459,900.90 $ 5,104.900  Million 11,100 
Medpace Holdings Inc   457,804.03 $ 2,838.385  Million 6,200 
Haemonetics Corporation  457,405.56 $ 1,382.737  Million 3,023 
Novocure Limited  451,955.14 $ 725.388  Million 1,605 
Omniab Inc   451,808.99 $ 40.211  Million 89 
Teladoc Health Inc   440,739.82 $ 2,468.143  Million 5,600 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.